DAVID ALTSHULER - 24 Feb 2022 Form 4 Insider Report for VERTEX PHARMACEUTICALS INC / MA (VRTX)

Signature
/s/ Sabrina Yohai, Attorney-in-Fact
Issuer symbol
VRTX
Transactions as of
24 Feb 2022
Net transactions value
-$3,124,808
Form type
4
Filing time
28 Feb 2022, 16:18:06 UTC
Previous filing
22 Feb 2022
Next filing
21 Jul 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VRTX Common Stock Tax liability $1,375,819 -6,038 -12% $227.86 43,649 24 Feb 2022 Direct
transaction VRTX Common Stock Sale $238,586 -1,040 -2.4% $229.41 42,609 25 Feb 2022 Direct F1, F2, F3
transaction VRTX Common Stock Sale $735,217 -3,188 -7.5% $230.62 39,421 25 Feb 2022 Direct F1, F3, F4
transaction VRTX Common Stock Sale $644,886 -2,784 -7.1% $231.64 36,637 25 Feb 2022 Direct F1, F3, F5
transaction VRTX Common Stock Sale $130,301 -560 -1.5% $232.68 36,077 25 Feb 2022 Direct F1, F3, F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Transaction made pursuant to Mr. Altshuler's company approved trading plan under Rule 10b5-1.
F2 Open market sales reported on this line occurred at a weighted average price of $229.41 (range $228.91 to $229.81).
F3 Mr. Altshuler undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
F4 Open market sales reported on this line occurred at a weighted average price of $230.62 (range $230.07 to $231.05).
F5 Open market sales reported on this line occurred at a weighted average price of $231.64 (range $231.08 to $232.07).
F6 Open market sales reported on this line occurred at a weighted average price of $232.68 (range $232.43 to $232.87).